Mount Sinai Comprehensive Cancer Center’s 2nd Annual Oncology Conference

Empowering Professionals & Advancing Evidence-Based Strategies in Cancer Care

The purpose of this symposium is to address the clinical challenges faced by oncology professionals in all practice settings regarding advances in
hematologic malignancies and breast cancer. Discussions will include how cancer molecular genetics is changing treatment outcomes, how integrative medicine can positively impact a patient’s cancer experience and what is the impact of sequencing systemic cancer therapies. The symposium will also include a review of how to recognize and treat fear and anxiety in persons with cancer.

  • Discuss how the integration of relevant clinical trial data into clinical practice has the potential to enhance outcomes in patients with hematologic malignancies
  • Assess how molecular and genetic abnormalities can be utilized in diagnosis, prognosis, risk stratification and therapy selection for patients with hematologic malignancies and breast cancers
  • Outline the benefits of integrative cancer care including how the use of dietary supplements and medical marijuana may be beneficial to integrate into conventional cancer care
  • Review the current surgical, medical oncology and radiation therapy treatment options for newly diagnosed breast cancer patients
  • Evaluate drug sequencing strategies in the era of novel immunotherapies, targeted agents and chemotherapeutic agents
  • Understand more about risk factors for anxiety and depression in cancer and how to implement best practices in distress management